Please login to the form below

Sage

This page shows the latest Sage news and features for those working in and with pharma, biotech and healthcare.

NHS test and trace system ‘still not good enough’ says health leader

According to the government’s Scientific Advisory Group (SAGE), 80% of the contacts of people with the virus need to self-isolate to prevent the infection rate rising.

Latest news

Intra-Cellular soars on FDA approval of schizophrenia drug

This includes Sage Therapeutics, Acadia Pharmaceutical, Karuna Therapeutics and even Biogen, which is looking for approval of its controversial Alzheimer’s drug.
Sage slides off a MOUNTAIN as depression drug flunks trial

Share price drops 60% as investors react to news. Sage Therapeutics was riding high in the summer after claiming an FDA approval for its first product, but just a few months ... The big cause of the decline was that disappointment that Sage will likely
Sage gets final US clearance for postpartum depression drug Zulresso

Controlled drug needs special REMS monitoring. Sage Therapeutics has gained clearance from the US Drug Enforcement Administration (DEA) to make its postpartum depression treatment Zulresso available to the first patients. ... for women with PPD and their
Sage’s postpartum depression treatment Zulresso gains US approval

The approval also represents the first product on the market for Sage Therapeutics. ... thought about and treated moving forward,” said Jeff Jonas, M.D., chief executive officer of Sage.
Sage raises $575m ahead of FDA review date for Zulresso

Company should get verdict by 19 March. In just under three weeks, Sage Therapeutics should hear back from the FDA on its filing for new antidepressant Zulresso, and the company has ... Sage already has a positive FDA advisory committee meeting in hand

More from news
Approximately 7 fully matching, plus 12 partially matching documents found.

Latest Intelligence

How merging firms can manage culture change

Globally, we've seen a deal struck between US firms Abbott and Alere for $5.8bn, while on the same day Stryker agreed to buy Sage for around $2.8bn.
Deal Watch February 2016

Turning to medtech, Stryker has had a busy month acquiring two companies, Sage Products and Physio-Control, paying over $4bn in cash for the two transactions. ... acquisition - company. 5, 800. Sage Products/ Stryker Corporation. portfolio of disposable

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

Horizon Discovery appoints executive director

Smoller joined Horizon as chief business officer as part of the form's acquisition of Sage Labs for $48m in September this year. ... company.”. His previous roles include the position of CEO at Sage Labs, chief scientific officer of Sigma-Aldrich and
Evoke Pharma adds to executive team

Dr Alves joins from Sage Clinical Development where he served as president and principal consultant.
Blue Latitude boosts senior management team

During her time as director of del Galdo Consulting, del Galdo worked with GSK &Ogilvy Common Health, Freesat, Thomson Reuters, Human Factors International, HomeAway, Sage, and Further on a variety of
Shires's Jeffrey Jonas to lead Sage

CNS appoints CEO alongside new CMO and CFO. Sage Therapeutics has made several changes at the top level, including the appointment of Shire's Dr Jeffrey Jonas as CEO. ... The changes come two years after the formation of the central nervous system (CNS)

More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

claire@dovetailstrategies.com

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

Surviving cancer: a new era for patients: Now more than ever, a shift in perspective is needed...
Crisis? No problem!: Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?: First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....